Shire is the global biotechnology leader serving patients with rare diseases and
specialized conditions. We seek to push boundaries through discovering and delivering
new possibilities for patient communities who often have few or no other champions.
Relentlessly on the edge of what’s next, we are serial innovators with a diverse pipeline
offering fresh thinking and new hope. Serving patients and partnering with healthcare
communities in over 100 countries, we strive to be part of the entire patient journey to
enable earlier diagnosis, raise standards of care, accelerate access to treatment, and
support patients. Our diverse portfolio of therapeutic areas includes Immunology,
Hematology, Genetic Diseases, Neuroscience, Internal Medicine, and Ophthalmics.
Championing patients is our call to action - it brings the opportunity - and responsibility -
to change people’s lives.